Skip to content
Shameless Cloning

Search Shameless Cloning

Search superinvestors, stocks, insiders and members of Congress

Q3 2026 13F · SEC CIK 1596452

Sivik Global Healthcare LLC

Hedge fundFiled 2026-10-13 for Q3 2026. Open the filing ↗ · All SEC filings ↗

Reported 13F value
$175.0M
Reported positions
35
Top holdings a year, 3 yrs
+13.6%
Assets under management
$233.9M

Sivik Global Healthcare LLC is a hedge fund that reported 35 positions worth $175.0M in its Q3 2026 13F, filed 2026-10-13. Its largest holdings were Spdr Series Trust (XBI, 16.2%), Humana Inc (HUM, 3.9%), Johnson & Johnson (JNJ, 3.6%). A portfolio copying its top holdings returned 13.6% a year over the last 3 years, against 20.4% for the S&P 500.

Sivik Global Healthcare LLC holdings all 35 positions.

Weights are shares of the filer's total reported 13F value, compared with Q2 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.

Sivik Global Healthcare LLC 13F holdings
Stock% of 13F valueShare changeReported value
XBISpdr Series Trust16.2%+20.0%$28.4M
HUMHumana Inc3.9%-11.5%$6.8M
JNJJohnson & Johnson3.6%+20.0%$6.4M
MRKMerck & Co Inc3.3%+0.0%$5.8M
ABBVAbbvie Inc3.3%+46.7%$5.8M
TMOThermo Fisher Scientific Inc3.3%+6.3%$5.7M
CAHCardinal Health Inc3.2%+4.2%$5.6M
MCKMckesson Corp3.2%+62.5%$5.5M
DHRDanaher Corp Del3.2%+25.0%$5.5M
UNHUnitedhealth Group Inc3.1%+50.0%$5.5M
VRTXVertex Pharmaceuticals Inc3.1%+5.0%$5.5M
ELVElevance Health Inc Formerly3.1%+180.0%$5.4M
ABTAbbott Laboratories3.1%+120.0%$5.4M
CORCencora Inc3.1%+20.0%$5.4M
AAgilent Technologies Inc3.0%+0.0%$5.2M
CNCCentene Corp Del2.8%—$5.0M
LLYEli Lilly & Co2.8%-15.4%$4.9M
EHCEncompass Health Corp2.8%+166.7%$4.9M
RVTYRevvity Inc2.6%—$4.6M
WATWaters Corp2.5%-33.3%$4.4M
BRKRBruker Corp2.4%—$4.2M
EWEdwards Lifesciences Corp2.2%+125.0%$3.9M
MDTMedtronic PLC2.2%—$3.9M
RGENRepligen Corp2.2%—$3.8M
MTDMettler Toledo International2.2%-9.1%$3.8M
GILDGilead Sciences Inc2.1%+0.0%$3.7M
CIThe Cigna Group2.0%—$3.6M
BIIBBiogen Inc1.9%+0.0%$3.4M
BIOBio Rad Labs Inc1.7%-20.0%$3.0M
AVTRAvantor Inc1.5%—$2.6M
BNTXBiontech SE1.2%—$2.2M
MRNAModerna Inc1.1%—$1.9M
ARGNFArgenx SE1.1%—$1.9M
MDGLMadrigal Pharmaceuticals Inc0.7%—$1.3M
TWSTTwist Bioscience Corp0.1%—$218K

What Sivik Global Healthcare LLC bought and sold in Q3 2026, against Q2 2026.

New positions

Added to

Reduced

Sold out

Share counts compared with the Q2 2026 13F; a split also changes share counts.

How the holdings did against the S&P 500.

1 year
+21.4% /yr
S&P 500 +20.1%
3 years
+13.6% /yr
S&P 500 +20.4%
5 years
+8.9% /yr
S&P 500 +11.6%

A portfolio of the filer's 20 largest 13F positions, weighted by value, bought the trading day after each 13F was filed and held until the next one was: what copying this filer could have earned. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.

Reported 13F value by quarter.

13F value by quarter
Quarter13F valuePositions
Q3 2026$175.0M35
Q2 2026$131.7M34
Q1 2026$131.7M34
Q4 2025$204.8M41
Q3 2025$190.5M35
Q2 2025$223.6M38
Q1 2025$182.9M29
Q4 2024$180.8M36
Q3 2024$234.6M33
Q2 2024$223.9M37
Q1 2024$275.1M46
Q4 2023$239.4M39

Questions about Sivik Global Healthcare LLC's portfolio

What stocks does Sivik Global Healthcare LLC own?

Sivik Global Healthcare LLC's latest 13F, for Q3 2026 and filed Oct 13, 2026, lists 35 positions worth $175.0M. The largest are Spdr Series Trust (XBI) at 16.2%, Humana Inc (HUM) at 3.9%, Johnson & Johnson (JNJ) at 3.6%, Merck & Co Inc (MRK) at 3.3% and Abbvie Inc (ABBV) at 3.3%.

What did Sivik Global Healthcare LLC buy last quarter?

In Q3 2026, Sivik Global Healthcare LLC added a new position in Centene Corp Del (CNC), a new position in Revvity Inc (RVTY), a new position in Bruker Corp (BRKR), a new position in Medtronic PLC (MDT), a new position in Repligen Corp (RGEN), Elevance Health Inc Formerly (ELV) (+180.0% shares), Encompass Health Corp (EHC) (+166.7% shares) and Edwards Lifesciences Corp (EW) (+125.0% shares), compared with its Q2 2026 filing.

What did Sivik Global Healthcare LLC sell last quarter?

In Q3 2026, Sivik Global Healthcare LLC sold all of Call- Bsx 100 @ 75 Exp 04/17/2026, sold all of Intuitive Surgical Inc (ISRG), sold all of Astrazeneca PLC (AZN), sold all of Boston Scientific Corp (BSX), sold all of Tenet Healthcare Corp (THC), Waters Corp (WAT) (-33.3% shares), Bio Rad Labs Inc (BIO) (-20.0% shares) and Eli Lilly & Co (LLY) (-15.4% shares), compared with its Q2 2026 filing.

How has Sivik Global Healthcare LLC's portfolio performed?

A portfolio copying Sivik Global Healthcare LLC's 20 largest 13F holdings each quarter, from the day each filing was public, returned +13.6% a year over the last 3 years, against +20.4% for the S&P 500. Over 1 year: +21.4% against +20.1%. Over 5 years: +8.9% a year against +11.6%.

When is Sivik Global Healthcare LLC's next 13F filing due?

13F filings are due 45 days after each quarter ends. Sivik Global Healthcare LLC's filing for the quarter ending Dec 31, 2026 is due by Feb 14, 2027; this page updates the day after it is published.

How much money does Sivik Global Healthcare LLC manage?

Sivik Global Healthcare LLC reported $233.9M of regulatory assets under management on its latest SEC Form ADV. Its 13F, which covers only US-listed stocks and options, totals $175.0M.